Down-regulation of CD28 expression by TNF-α

Journal of Immunology

Volumn 167, Issue 6, 2001, Pages 3231-3238

  Bryl, E ^a   Vallejo, A N ^a   Weyand, C M ^a   Goronzy, J J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; BIOASSAY; CELL SURFACE; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA PROTEIN COMPLEX; DNA SEQUENCE; DNA TEMPLATE; GENE INACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOCYTE CLONE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; T LYMPHOCYTE; TATA BOX; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

EID: 0035884911     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.6.3231     Document Type: Article

References (58)

1. CD28/B7 system of T cell costimulation
2. Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy
3. L
4. Differential T cell costimulatory requirements in CD28-deficient mice
5. Modulation of CD28 expression: Distinct regulatory pathways during activation and replicative senescence
6. + T-cell apoptosis in patients with acute herpesvirus infections: Loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression
7. + T lymphocytes during HIV-1 infection
8. + T cells in severe rheumatoid arthritis
9. Costimulatory molecules in Wegener's granulomatosis (WG): Lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells
10. Perturbation of the T-cell repertoire in patients with unstable angina
11. + T cells is associated with the loss of gene-specific nuclear factor binding activity
12. Functional disruption of the CD28 gene transcriptional initiator in senescent T cells
13. CD28/B7 costimulation: A review
14. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity
15. Role of cytokines in rheumatoid arthritis
16. Regulation of autoimmunity by proinflammatory cytokines
17. Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
18. Prolonged exposure of T cells to TNF down-regulates TCRζ and expression of the TCR/CD3 complex at the cell surface
19. MAP3K-related kinase involved in NFκB induction by TNF, CD95, and IL-1
20. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of nuclear factor κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2
21. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF
22. Overlapping pathways mediate the opposing actions of tumor necrosis factor α and transforming growth factor β on α2(I) collagen gene transcription
23. A mechanism of suppression of TGFβ/SMA signaling by NFκB/RelA
24. Increased cytokine production in mononuclear cells of healthy elderly people
25. Quantitative intracellular cytokine measurement: Age-related changes in proinflammatory cytokine production
26. null T cells are associated with defects in apoptotic pathways
27. Protease inhibitors induce specific changes in protein tyrosine phosphorylation that correlate with inhibition of apoptosis in myeloid cells
28. Quantitative analysis of lymphocyte differentiation and proliferation in vitro using carboxyfluorescein diacetate succinimidyl ester
29. The locus-specific enhancer activity of the class I major histocompatibility complex interferon-responsive element is associated with a γ-interferon (IFN)-inducible factor distinct from STAT1α, p48, and IFN regulatory factor-1
30. In vitro synthesis of novel genes: Mutagenesis and recombination by PCR
31. CIF150, a human cofactor for transcription factor IID-dependent initiator function
32. CIF, an essential cofactor for TFIID-dependent initiator function
33. Signaling by tumor necrosis factor receptors: Pathways, paradigms and targets for therapeutic modulation
34. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
35. Tumor necrosis factor receptor and Fas signaling mechanisms
36. The genomic organization of the CD28 gene: Implications for the regulation of CD28 mRNA expression and heterogeneity
37. Modulation by interleukin-1 and tumor necrosis factor α of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chrondrocytes
38. Potent inhibition of the master chondrogenic factor Sox9 gene by interleukin-1 and tumor necrosis factor α
39. Transcription by RNA polymerase II: Initiator-directed formation of transcription-competent complexes
40. DNA sequence requirements for transcriptional initiator activity in mammalian cells
41. Transcription of the lymphocyte-specific terminal deoxynucleotidyltransferase gene requires a specific core promoter structure
42. TFII is required for transcription of the naturally TATA-less but initiator-containing Vβ promoter
43. An initiator element is required for maximal human chorionic somatomammotropin gene promoter and enhancer function
44. Restriction of interferon γ responsiveness and basal expression of the myeloid human Fcγ RIb gene is mediated by a functional PU.1 site and a transcription initiator consensus
45. Interferon regulatory factors and TFIIB cooperatively regulate interferon-responsive promoter activity in vivo and in vitro
46. Promoter architecture, cofactors, and orphan receptors contribute to cell-specific activation of the retinoic acid receptor β2 promoter
47. Mutational analysis of the adenovirus 2 IVa2 initiator and downstream elements
48. Direct recognition of initiator elements by a component of the transcription factor IID complex
49. DNA binding site selection by RNA polymerase II TAFs: A TAF(II)250-TAF(II)150 complex recognizes the initiator
50. A Myc-associated zinc finger protein binding site is one of four important functional regions in the CD4 promoter
51. Deletional and mutational analyses of the human CD4 gene promoter: Characterization of a minimal tissue-specific promoter
52. Generality of a functional initiator consensus sequence
53. CD28 expression by mouse mast cells is modulated by lipopolysaccharide and outer surface protein A lipoprotein from Borrelia burgdorferi
54. TNF induces internalization of the p60 receptor and shedding of the p80 receptor
55. The importance of shedding of membrane proteins for cytokine biology
56. Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
57. Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis
58. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate